Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Am J Transplant. 2010 Jul;10(7):1686–1694. doi: 10.1111/j.1600-6143.2010.03141.x

Recommendations for the Assessment and Reporting of Multivariable Logistic Regression in Transplantation Literature

Andre C Kalil 1, Jane Mattei 2, Diana F Florescu 1, Junfeng Sun 3, Roberto S Kalil 4
PMCID: PMC2909008  NIHMSID: NIHMS203841  PMID: 20642690

Abstract

Multivariable logistic regression is an important method to evaluate risk factors and prognosis in solid organ transplant literature. We aimed to assess the quality of this method in six major transplantation journals.

Eleven analytical criteria and four documentation criteria were analyzed for each selected article that used logistic regression.

A total of 106 studies (6%) out of 1,701 original articles used logistic regression analyses from January 1, 2005 to January 1, 2006. The analytical criteria and their respective reporting percentage among the six journals were: Linearity (25%); Beta coefficient (48%); Interaction tests (19%); Main estimates (98%); Ovefitting prevention (84%); Goodness-of-fit (3.8%); Multicolinearity (4.7%); Internal validation (3.8%); External validation (8.5%). The documentation criteria were reported as follows: Selection of independent variables (73%); Coding of variables (9%); Fitting procedures (49%); Statistical program (65%). No significant differences were found among different journals or between general versus subspecialty journals with respect to reporting quality. We found that the report of logistic regression is unsatisfactory in transplantation journals. Because our findings may have major consequences for the care of transplant patients and for the design of transplant clinical trials, we recommend a practical solution for the use and reporting of logistic regression in transplantation journals.

Keywords: multivariable, logistic, regression, transplantation

INTRODUCTION

“We live in a multivariable world” (1) and most events in life are multifactorial, i.e. many different factors (i.e. variables) are associated to a specific outcome. Multivariable logistic regression is one of the tools that help to determine the contribution of each of these factors to a single outcome. Multivariable logistic regression is an important statistical method commonly used in all fields of Medicine and Surgery, as well as in the solid organ transplant literature. This method is mainly used to either understand the effect of several variables (e.g. risk factors) that may ‘explain’ changes in specific outcomes (e.g. allograft rejection) – also called explanatory modeling, or that may ‘predict’ changes in specific outcomes (e.g. patient survival) - predictive modeling. Of note, while the explanatory or predictor variables being analyzed can be continuous -also called numerical due to the presence of multiple levels (e.g tacrolimus levels), or dichotomous, also called binary due to the presence of two levels (e.g. gender male vs. female), the outcome variable must be dichotomous for most logistic regression analyses.

Landmark studies evaluating this methodology in four major medical journals -NEJM, JAMA, ANNALS, and BMJ - have consistently demonstrated important analytic and reporting problems (24) concerning the reporting of multivariable regression analyses. These problems have important bedside implications considering that the regression analyses results from published studies may be inaccurate and lead to inappropriate application to the clinical or surgical care of transplant patients.

We performed an assessment of the quality of logistic regression models in the solid organ transplant literature. In order to perform this study, we conducted a systematic review of the literature in six major transplantation journals. Then, we used specific criteria to evaluate the quality of the studies which used logistic regression models. Finally, we analyzed the overall proportion of articles with adequate methodology within each assessment criterion, addressed the magnitude and clinical importance of the observed methodology inadequacies, and provided solutions for the better utilization of logistic regression models in the transplant literature.

METHODS

We developed our initial assessment criteria based on three studies (57) and one expert guideline by the American College of Physicians (8). Further modifications were made according to six other studies (24, 911).

a) Transplantation Journals Selected For Data Extraction

All original articles including the keywords “multiple, multivariable, multivariate, logistic, linear, regression, model, method, risks, prediction, rules”, and published from January 1, 2005 to January 1, 2006 were searched in PubMed for the following journals: General transplantation journals: American Journal of Transplantation; Transplantation; and Clinical Transplantation. Subspecialty journals: Nephrology Dialysis Transplantation; Liver Transplantation; and Journal of Heart and Lung Transplantation.

The reasons for choosing the year of 2005–2006 were the following: 1) to allow PubMed enough time to correct reporting mistakes commonly seen after articles’ release; 2) to not miss articles which were retroactively placed in PubMed; 3) to allow time for potential articles retrievals from each journal; 4) to allow time for the PubMed incorporation of errors discovered after final publications; and 5) to allow time for us to assess letters to the editor concerning each selected article.

It is of importance to remind the reader that what was reported in a manuscript may not have always reflected what was actually done in its entirety. However, reporting itself was the main focus of our study, thus we assumed that the published reports encompassed and represented most of what was performed for their regression analyses.

Both Fisher’s exact test and Chi-squared test were performed for all criteria comparisons between journals. A pre-determined alpha error threshold of 0.05 (two-tailed) was used. Due to the small sample size of each category and the expected frequency of some cells being less than 5, which makes Chi-squared test results less reliable, we only report results from Fisher’s exact test.

b) Analytical Criteria

  1. Presence of linearity for continuous or transformed categorical variables:

    • Inadequate: no description of the linearity assumption

    • Adequate: description of the linearity assumption. Preferably some kind of justification is provided, e.g. prior clinical knowledge, exploratory plot of the data.

  2. Presence of multiple regression equation or table:

    • Inadequate: no report of coefficients and associated standard errors.

    • Adequate: report of each coefficients and associated standard errors.

  3. Test for interaction for independent variables:

    • Inadequate: use of interaction term without providing its statistical or clinical justification.

    • Adequate: use of interaction term providing its statistical or clinical justification.

  4. Main effect estimates, 95%CI, and statistical significance:

    • Inadequate: odds ratio and 95%CI (or p values) for each variable included in the final model is not provided.

    • Adequate: odds ratio and 95%CI (or p values) for each variable included in the final model is provided.

  5. Prevention of overfitting:

    • Inadequate: The ratio between the number of the less common outcomes and the number of independent variable parameters is less than 10.

    • Adequate: the ratio is equal or greater than 10.

  6. Report of outlying data:

    • Inadequate: If present, no report about how these data were treated.

    • Adequate: If present, report about how these data were treated.

  7. Goodness-of-fit procedures:

    • Inadequate: no reporting of goodness-of-fit test (e.g. Hosmer-Lemeshow test) or regression diagnostics.

    • Adequate: reporting of goodness-of-fit test (e.g. Hosmer-Lemeshow test) or regression diagnostics. Area under ROC curve should be provided if prediction is of interest.

  8. Multicolinearity of predictive models:

    • Inadequate: If high correlation between two independent variables is discussed in the paper, but a test for colinearity is not provided.

    • Adequate: If high correlation between two independent variables is discussed in the paper and a test for colinearity is provided.

  9. Internal validation of predictive models:

    • Inadequate: no data-splitting (including cross-validation), or bootstrapping, or jackknife.

    • Adequate: provision of at least one of these 3 procedures.

  10. External validation of predictive models:

    • Inadequate: not prospectively studied in a different patient population.

    • Adequate: prospectively studied in a different patient population.

  11. Evidence for clinical decision rules:

    • Level 1: At least one prospective validation in a different population and one impact analysis, demonstrating change in clinician behavior and improve patient outcomes.

    • Level 2: At least one prospective validation in a broad spectrum of patients and clinicians, or validated in several smaller settings that differ from one another.

    • Level 3: At least one prospective validation in a narrow spectrum of patients, similar to those evaluated in the derivation sample.

    • Level 4: Just internal validation (data-splitting, bootstrapping, jackknife) from retrospective data.

    • Level 5: Derivation only. No internal validation.

c) Documentation Criteria

  1. Selection of independent variables:

    • Inadequate: no provision of the rationale for including each variable.

    • Adequate: provision of the rationale for including each variable, e.g. prior studies/clinical knowledge, exploratory analysis.

  2. Coding of independent variables:

    • Inadequate: if variables included in the model can not have coding identifiable by our team.

    • Adequate: if variables included in the model have coding identifiable by our team.

  3. Fitting procedure:

    • Inadequate: no provision of how the final model was selected.

    • Adequate: provision of model selection method used, such as automatic procedures (e.g. forward inclusion or backward elimination or stepwise or best subset, preferably with description of the criteria used), non-automated backward selection, or prior knowledge.

  4. Statistical program:

    • Inadequate: no provision of software used.

    • Adequate: provision of software used.

RESULTS

a) Selected Studies

A total of 106 studies out of 1,701 original articles (6%) used logistic regression analyses in the six transplantation journals during the year of January 1 2005 to January 1, 2006: Forty-six articles were selected from general transplantation journals (American Journal of Transplantation [11 studies] (1222); Transplantation [27 studies] (2349); and Clinical Transplantation [8 studies] (5057); and sixty from subspecialty transplantation journals (Nephrology Dialysis Transplantation [28 studies] (5885); Liver Transplantation [20 studies] (86105); and Journal of Heart and Lung Transplantation [12 studies] (106117).

b) Results for the Analytical Criteria

Ten out of the twelve analytical criteria results are described in table 1. Criterion number 7 (report of outlying data) had zero reports out of 106 studies. Criterion number 12 (evidence for clinical decision rules) showed the following results: For general transplant journals (level 5 [39 studies]; level 4 [3]; level 3 [3]; level 2 [1]; level 1 [0]); For subspecialty transplant journals (level 5 [36 studies]; level 4 [4]; level 3 [16]; level 2 [4]; level 1 [0]).

Table 1.

Adequacy of Analytical Criteria: Number (%)

Transplant Journal Report of Linearity Report of β (SE)1 Report of Interaction Tests Report of Main Estimates Report of Overfitting Prevention Goodness- Report of of-fit Report of Multicolinearity Internal Validation External Validation
General2 12/46 (26%) 20/46 (43%) 7/46 (15%) 44/46 (96%) 36/46 (78%) 2/46 (4.3%) 1/46 (2.2%) 2/46 (4.3%) 3/46 (6.5%)
Subspecialty3 15/60 (25%) 31/60 (52%) 13/60 (22%) 60/60 (100%) 53/60 (88%) 2/60 (3.3%) 4/60 (6.7%) 2/60 (3.3%) 6/60 (10%)
P value4 1.00 0.44 0.46 0.19 0.19 1.00 0.38 1.00 0.73
Total 27/106 (25%) 51/106 (48%) 20/106 (19%) 104/106 (98%) 89/106 (84%) 4/106 (3.8%) 5/106 (4.7%) 4/106 (3.8%) 9/106 (8.5%)
1

Regression coefficient and standard error

2

American Journal of Transplantation; Transplantation; and Clinical Transplantation.

3

Nephrology Dialysis Transplantation; Liver Transplantation; and Journal of Heart and Lung Transplantation.

4

P value for the comparison between general and subspecialty journals.

c) Results for the Documentation Criteria

All documentation criteria results are described in table 2.

Table 2.

Adequacy of Documentation Criteria: Number (%)

DOCUMENTATION CRITERIA RESULTS
Transplant Journal Selection of Independent Variables Coding of Independent Variables Description of Fitting Procedure Description of Statistical Program
General1 30/46 (65%) 4/46 (8.7) 20/46 (43%) 25/46 (54%)
Subspecialty2 47/60 (78%) 6/60 (10%) 32/60 (53%) 44/60 (73%)
P value3 0.19 1.00 0.33 0.06
Total 77/106 (73%) 10/106 (9%) 52/106 (49%) 69/106 (65%)
1

American Journal of Transplantation; Transplantation; and Clinical Transplantation.

2

Nephrology Dialysis Transplantation; Liver Transplantation; and Journal of Heart and Lung Transplantation.

3

P value for the comparison between general and subspecialty journals.

d) Results for the comparison among journals

All p values were greater than 0.05 for each criterion comparison between different journals, as well for each criterion comparison between general versus subspecialty transplantation journals (tables 1 and 2).

DISCUSSION

Our findings demonstrate that logistic regression analyses are unsatisfactorily reported in transplantation research, both in general and subspecialty journals. The report of main estimates and the prevention of model overfitting were the only analytical criteria reported by the majority of journals (84–98%), and the selection of independent variables was the documentation criterion with the highest reporting rate (65–78%). While 10 or more outcome events per variable is a traditional rule to prevent model overfitting (6, 118, 119), there is recent evidence that a minimum of 8 events per variable should produce models as well fit as the ones with 21 events per variable (120). These fitting rules are very helpful but are not perfect since relevant variables may end excluded by following these guidelines too strictly.

The criterion with the lowest reporting rate among all was the goodness-of-fit, which was present in just 4% of all papers. Goodness-of-fit tests are useful to understand how well the model fits the data, that is, how well the model reflects the data on which it was generated. If this test reveals a lack-of-fit, the final results of the logistic regression may be severely compromised and potentially unreliable. This is an area in which studies have definitely to improve.

The report of multicolinearity was low for all journals (4.7%). Multicolinearity is an important analytical criterion that determines if two or more variables are parallel or collinear, which implies that they are not independent from each other (an implicit assumption of all logistic models). For example, inappropriate low levels of tacrolimus post-transplant and poor patient adherence with medication intake in a model evaluating allograft rejection as the outcome (dependent) variable – both can increase the risk of rejection. If these non-independent variables are kept in the model, it is possible that the statistical association may be reported as absent despite the fact there is a statistically significant association with one of these variables. In other words, despite the fact that inappropriate low levels of tacrolimus is associated with higher rejection rate, the inclusion of this variable in addition to the poor compliance variable in the same logistic model may produce falsely negative results. If multicolinearity is detected, then one of the variables - usually the one with the weakest relationship - should be removed from the model.

Interaction tests should be a routine part of all logistic regression reports, but we found it present in only 19% of the publications in transplant journals. The reason for its importance is that the effect of one variable on the outcome would depend on the effects of a second variable. For example, we consider delayed kidney graft function (defined as the need for dialysis within the first week post transplant) and acute cellular rejection as variables for a logistic model evaluating allograft survival (outcome variable). Either variable may not show significant association with the study main outcome (or either may show a weak association), but when both are analyzed together as a single “interaction variable”, the results may change drastically. That is why interaction effects are also called “modification effects”. Opposite to the multicolinearity solution (exclusion of one variable), statistically significant interaction demonstrate that both variables should be kept together until the final regression model.

Interestingly, the report of external validation was low (8.5%) and this was expected because of the inherent logistic difficulties of applying regression results to other patient populations and institutions. However, the finding of an another population cohort to perform an external validation may not be possible due to inherent difficulties associated to recruiting the adequate number of subjects to perform another analysis, especially in single-center studies. On the other side, the quite low rate of internal validation (3.8%) was unexpected because this can be easily done even with a retrospective analysis from a single institution, which is a common setting for logistic regression analyses. The authors would have to either split the data or perform repeated simulations within the original population, then use procedures called data-splitting, bootstrapping, or jackknife to perform internal validation. This type of validation brings the original regression findings to another level of reliability because the original results have to stand despite the use of different subset of patients.

In general, documentation criteria were better reported than that of analytical criteria. Seventy three percent of the manuscripts mentioned the reasons for the selection of independent variables. This is an optimistic finding because the reader must know the rationale for all the variables entered into the model. Surprisingly, the description of statistical programs was seen only in 65% of the publications. This should be standard request from every journal not only because the data can be further verified by the use of the same software, but also because the peer-reviewers can request further information based on the capabilities of the program being used by the authors.

It is unfortunate that the fitting procedures were reported in 49% of the papers. There are specific technical indications for simultaneous or hierarchical (e.g. forward inclusion or backward elimination) procedures to be used. Different fitting procedures may result in substantially different study results, therefore, the clear specification of the type of procedure and the reasons for choosing it are essential for the quality of the regression analyses report. The coding of the independent variables was rare (9%), but we do not believe that the cumbersome addition of the coding for each variable would add substantial information to the physician. On the other hand, this could be provided as an electronic appendix.

One possible limitation of these data is that not all articles using regression analyses were included in this study; if for example, they did not have one of the key words to meet our search criteria. We don’t have data to estimate whether or not 6% of the publication is the correct fraction of studies using regression analysis for that given year, but we believe this number (106 studies) is representative of the majority of the articles using regression analysis during the selected period. Another argument against our findings could be based on the relatively low rate of use for this method −6%. However, we strongly believe that the results from these 6% have substantial influence in both patient care and future research because statistically significant risk factors by logistic regression are used not only in the direct assessment of transplant patients (e.g. which patients are at higher risk for cytomegalovirus infections), but also in the design of future clinical trials (e.g. which patients should be enrolled in a trial evaluating a new drug to prevent cytomegalovirus infections). The logistic regression findings concerning prognostic factors would have similar applicability in both clinical and research settings. Another limitation concerns to the possible redundant information provided by items 2 and 4 of the analytical criteria: both lead to the reporting of the odds ratio and confidence intervals, but the reporting of beta values and standard errors gives the reader an extra opportunity to more precisely evaluate the regression equation, and potentially apply this equation to his/her institution. Variables that depend on time were not evaluated in our study because the logistic regression model can not account for time to event or censored events (e.g. events that did not happened until the end of study follow up); other statistical methods such as the Cox proportional hazards regression analysis would be more appropriate for these variables. Last, we did not perform inter-rate reliability analyses, however, except for two disagreements resolved by consensus, authors agreed about everything else.

We propose two solutions in order to improve the report of regression analyses: 1) Transplantation journals should have a concise but obligatory list of requests for all manuscripts that use the logistic regression technique. Our suggestions for this list are described in table 3. If the requirements are not met at first submission, the paper should not be sent out for peer-review; 2) If one or more peer-reviewers still raises questions about the logistic regression report, the journal should ask for an independent statistician to perform a specific review of the technical aspects of the analyses. Also, journal editors should increase the emphasis on a more comprehensive description of study methods section; space limitation should not be an excuse for short methods’ section anymore since nowadays most journal websites can publish electronic appendices of any size.

Table 3.

Suggestions for Transplantation Journals “Minimal Requirements” for the Reporting of Logistic Regression Analyses

1) Report of Odds Ratio and 95%CI
2) Report of Overfitting Prevention Procedures
3) Report of Goodness-of-Fit Procedures
4) Report of Multicolinearity Tests
5) Report of Interaction Tests
6) Internal Validation (if sample size allows)
7) Report of the Selection of Independent Variables
8) Report of Statistical Program

In conclusion, we found that the report of logistic regression is unsatisfactory in transplantation articles. Because this finding may have major consequences for the care of transplant patients, we believe that journal editors should be more pro-active and specific about the requirements for the publication of studies with logistic regression analyses. We hope that through our dissection of the major reporting problems with logistic regression studies and our suggestions for possible resolutions, we may stimulate both authors and editors to further refine the report of their next logistic regression manuscript.

Acknowledgments

We thank Ms. Elaine Litton for providing outstanding administrative work.

R.S.K. is supported by a grant from the National Heart and Lung and Blood Institute (NHLBI # 5K23 HL08410-02) and by a Clinician Scientist Award from the National Kidney Foundation (NKF).

Funding sources: None

References

  • 1.Katz MH. Multivariable analysis: a practical guide for clinicians. 2. Cambridge; New York: Cambridge University Press; 2006. [Google Scholar]
  • 2.Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Applications and methodological standards. N Engl J Med. 1985;313(13):793–799. doi: 10.1056/NEJM198509263131306. [DOI] [PubMed] [Google Scholar]
  • 3.Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. Jama. 1997;277(6):488–494. [PubMed] [Google Scholar]
  • 4.Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med. 2006;144(3):201–209. doi: 10.7326/0003-4819-144-3-200602070-00009. [DOI] [PubMed] [Google Scholar]
  • 5.Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol. 2001;54(10):979–985. doi: 10.1016/s0895-4356(01)00372-9. [DOI] [PubMed] [Google Scholar]
  • 6.Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med. 1993;118(3):201–210. doi: 10.7326/0003-4819-118-3-199302010-00009. [DOI] [PubMed] [Google Scholar]
  • 7.Katz MH. Multivariable analysis: a primer for readers of medical research. Ann Intern Med. 2003;138(8):644–650. doi: 10.7326/0003-4819-138-8-200304150-00012. [DOI] [PubMed] [Google Scholar]
  • 8.Lang TA, Secic M. How to report statistics in medicine: annotated guidelines for authors, editors, and reviewers. Philadelphia, Pa: American College of Physicians; 1997. [Google Scholar]
  • 9.Braitman LE, Davidoff F. Predicting clinical states in individual patients. Ann Intern Med. 1996;125(5):406–412. doi: 10.7326/0003-4819-125-5-199609010-00008. [DOI] [PubMed] [Google Scholar]
  • 10.McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. Jama. 2000;284(1):79–84. doi: 10.1001/jama.284.1.79. [DOI] [PubMed] [Google Scholar]
  • 11.Moss M, Wellman DA, Cotsonis GA. An appraisal of multivariable logistic models in the pulmonary and critical care literature. Chest. 2003;123(3):923–928. doi: 10.1378/chest.123.3.923. [DOI] [PubMed] [Google Scholar]
  • 12.Boulware LE, Meoni LA, Fink NE, Parekh RS, Kao WH, Klag MJ, et al. Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families. Am J Transplant. 2005;5(6):1503–1512. doi: 10.1111/j.1600-6143.2005.00860.x. [DOI] [PubMed] [Google Scholar]
  • 13.Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU. Are we frozen in time?. Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant. 2005;5(7):1681–1688. doi: 10.1111/j.1600-6143.2005.00910.x. [DOI] [PubMed] [Google Scholar]
  • 14.Mitsnefes MM, Subat-Dezulovic M, Khoury PR, Goebel J, Strife CF. Increasing incidence of post-kidney transplant anemia in children. Am J Transplant. 2005;5(7):1713–1718. doi: 10.1111/j.1600-6143.2005.00919.x. [DOI] [PubMed] [Google Scholar]
  • 15.Rosas SE, Mensah K, Weinstein RB, Bellamy SL, Rader DJ. Coronary artery calcification in renal transplant recipients. Am J Transplant. 2005;5(8):1942–1947. doi: 10.1111/j.1600-6143.2005.00955.x. [DOI] [PubMed] [Google Scholar]
  • 16.Woodle ES, Alloway RR, Buell JF, Alexander JW, Munda R, Roy-Chaudhury P, et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant. 2005;5(11):2740–2744. doi: 10.1111/j.1600-6143.2005.01090.x. [DOI] [PubMed] [Google Scholar]
  • 17.Carter JT, Chan S, Roberts JP, Feng S. Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center. Am J Transplant. 2005;5(11):2745–2753. doi: 10.1111/j.1600-6143.2005.01095.x. [DOI] [PubMed] [Google Scholar]
  • 18.Singer LG, Gould MK, Tomlinson G, Theodore J. Determinants of health utility in lung and heart-lung transplant recipients. Am J Transplant. 2005;5(1):103–109. doi: 10.1111/j.1600-6143.2004.00641.x. [DOI] [PubMed] [Google Scholar]
  • 19.Villiger P, Ryan EA, Owen R, O’Kelly K, Oberholzer J, Al Saif F, et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant. 2005;5(12):2992–2998. doi: 10.1111/j.1600-6143.2005.01108.x. [DOI] [PubMed] [Google Scholar]
  • 20.Berger SP, Roos A, Mallat MJ, Fujita T, de Fijter JW, Daha MR. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant. 2005;5(6):1361–1366. doi: 10.1111/j.1600-6143.2005.00841.x. [DOI] [PubMed] [Google Scholar]
  • 21.Ducloux D, Kazory A, Simula-Faivre D, Chalopin JM. One-year post-transplant weight gain is a risk factor for graft loss. Am J Transplant. 2005;5(12):2922–2928. doi: 10.1111/j.1600-6143.2005.01104.x. [DOI] [PubMed] [Google Scholar]
  • 22.Boulware LE, Ratner LE, Troll MU, Chaudron A, Yeung E, Chen S, et al. Attitudes, psychology, and risk taking of potential live kidney donors: strangers, relatives, and the general public. Am J Transplant. 2005;5(7):1671–1680. doi: 10.1111/j.1600-6143.2005.00896.x. [DOI] [PubMed] [Google Scholar]
  • 23.Jacob M, Copley LP, Lewsey JD, Gimson A, Rela M, van der Meulen JH. Functional status of patients before liver transplantation as a predictor of posttransplant mortality. Transplantation. 2005;80(1):52–57. doi: 10.1097/01.tp.0000163292.03640.5c. [DOI] [PubMed] [Google Scholar]
  • 24.Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation. 2005;80(1):145–148. doi: 10.1097/01.tp.0000164291.35925.7a. [DOI] [PubMed] [Google Scholar]
  • 25.Bogunia-Kubik K, Lange A. HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease. Transplantation. 2005;79(7):815–820. doi: 10.1097/01.tp.0000153157.97736.2c. [DOI] [PubMed] [Google Scholar]
  • 26.Tinckam K, Rush D, Hutchinson I, Dembinski I, Pravica V, Jeffery J, et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation. 2005;79(7):836–841. doi: 10.1097/01.tp.0000155187.81806.df. [DOI] [PubMed] [Google Scholar]
  • 27.Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation. 2005;80(7):883–889. doi: 10.1097/01.tp.0000184006.43152.8d. [DOI] [PubMed] [Google Scholar]
  • 28.Armstrong KA, Hiremagalur B, Haluska BA, Campbell SB, Hawley CM, Marks L, et al. Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients. Transplantation. 2005;80(7):937–944. doi: 10.1097/01.tp.0000173792.53561.b6. [DOI] [PubMed] [Google Scholar]
  • 29.de Groot K, Bahlmann FH, Bahlmann E, Menne J, Haller H, Fliser D. Kidney graft function determines endothelial progenitor cell number in renal transplant recipients. Transplantation. 2005;79(8):941–945. doi: 10.1097/00007890-200504270-00012. [DOI] [PubMed] [Google Scholar]
  • 30.Thaunat O, Beaumont C, Chatenoud L, Lechaton S, Mamzer-Bruneel MF, Varet B, et al. Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state. Transplantation. 2005;80(9):1212–1219. doi: 10.1097/01.tp.0000179106.07382.6a. [DOI] [PubMed] [Google Scholar]
  • 31.Baggio B, Budakovic A, Ferraro A, Checchetto S, Priante G, Musacchio E, et al. Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation. Transplantation. 2005;80(9):1349–1352. doi: 10.1097/01.tp.0000179152.57167.c1. [DOI] [PubMed] [Google Scholar]
  • 32.Schulte CM, Beelen DW. Low pretransplant bone-mineral density and rapid bone loss do not increase risk for avascular osteonecrosis after allogeneic hematopoietic stem cell transplantation. Transplantation. 2005;79(12):1748–1755. doi: 10.1097/01.tp.0000164353.86447.db. [DOI] [PubMed] [Google Scholar]
  • 33.Lauzurica R, Pastor C, Bayes B, Hernandez JM, Romero R. Pretransplant pregnancy-associated plasma protein-a as a predictor of chronic allograft nephropathy and posttransplant cardiovascular events. Transplantation. 2005;80(10):1441–1446. doi: 10.1097/01.tp.0000185199.67531.1a. [DOI] [PubMed] [Google Scholar]
  • 34.Hwang AH, Cho YW, Cicciarelli J, Mentser M, Iwaki Y, Hardy BE. Risk factors for short- and long-term survival of primary cadaveric renal allografts in pediatric recipients: a UNOS analysis. Transplantation. 2005;80(4):466–470. doi: 10.1097/01.tp.0000168090.19875.b0. [DOI] [PubMed] [Google Scholar]
  • 35.Dabos KJ, Newsome PN, Parkinson JA, Davidson JS, Sadler IH, Plevris JN, et al. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation. 2005;80(12):1712–1717. doi: 10.1097/01.tp.0000187879.51616.e0. [DOI] [PubMed] [Google Scholar]
  • 36.Franek E, Blach A, Witula A, Kolonko A, Chudek J, Drugacz J, et al. Association between chronic periodontal disease and left ventricular hypertrophy in kidney transplant recipients. Transplantation. 2005;80(1):3–5. doi: 10.1097/01.tp.0000158716.12065.24. [DOI] [PubMed] [Google Scholar]
  • 37.Kaller T, Schulz KH, Sander K, Boeck A, Rogiers X, Burdelski M. Cognitive abilities in children after liver transplantation. Transplantation. 2005;79(9):1252–1256. doi: 10.1097/01.tp.0000161251.20520.42. [DOI] [PubMed] [Google Scholar]
  • 38.Lemos FB, Mol WM, Roodnat JI, Uitterlinden A, Ijzermans JN, Weimar W, et al. The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation. Transplantation. 2005;79(9):1221–1225. doi: 10.1097/01.tp.0000161219.75906.ec. [DOI] [PubMed] [Google Scholar]
  • 39.Numakura K, Satoh S, Tsuchiya N, Horikawa Y, Inoue T, Kakinuma H, et al. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation. 2005;80(10):1419–1424. doi: 10.1097/01.tp.0000181142.82649.e3. [DOI] [PubMed] [Google Scholar]
  • 40.Press R, Carrasquillo O, Nickolas T, Radhakrishnan J, Shea S, Barr RG. Race/ethnicity, poverty status, and renal transplant outcomes. Transplantation. 2005;80(7):917–924. doi: 10.1097/01.tp.0000173379.53347.31. [DOI] [PubMed] [Google Scholar]
  • 41.Zheng L, Orsida B, Whitford H, Levvey B, Ward C, Walters EH, et al. Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation. Transplantation. 2005;80(2):185–192. doi: 10.1097/01.tp.0000165091.31541.23. [DOI] [PubMed] [Google Scholar]
  • 42.Tamouza R, Rocha V, Busson M, Fortier C, El Sherbini SM, Esperou H, et al. Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation. Transplantation. 2005;80(1):140–144. doi: 10.1097/01.tp.0000158711.37550.a0. [DOI] [PubMed] [Google Scholar]
  • 43.Dobbels F, Vanhaecke J, Desmyttere A, Dupont L, Nevens F, De Geest S. Prevalence and correlates of self-reported pretransplant nonadherence with medication in heart, liver, and lung transplant candidates. Transplantation. 2005;79(11):1588–1595. doi: 10.1097/01.tp.0000158430.06507.87. [DOI] [PubMed] [Google Scholar]
  • 44.Elmaagacli AH, Ottinger H, Koldehoff M, Peceny R, Steckel NK, Trenschel R, et al. Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor. Transplantation. 2005;79(12):1741–1747. doi: 10.1097/01.tp.0000164500.16052.3c. [DOI] [PubMed] [Google Scholar]
  • 45.Funch DP, Ko HH, Travasso J, Brady J, Kew CE, 2nd, Nalesnik MA, et al. Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil. Transplantation. 2005;80(9):1174–1180. doi: 10.1097/01.tp.0000169035.10572.c6. [DOI] [PubMed] [Google Scholar]
  • 46.Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients. Transplantation. 2005;80(12):1773–1782. doi: 10.1097/01.tp.0000184624.54005.9f. [DOI] [PubMed] [Google Scholar]
  • 47.Lazzeri E, Rotondi M, Mazzinghi B, Lasagni L, Buonamano A, Rosati A, et al. High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. Transplantation. 2005;79(9):1215–1220. doi: 10.1097/01.tp.0000160759.85080.2e. [DOI] [PubMed] [Google Scholar]
  • 48.Toniutto P, Fabris C, Minisini R, Apollonio L, Fumo E, Caldato M, et al. Weight gain after liver transplantation and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Transplantation. 2005;79(10):1338–1343. doi: 10.1097/01.tp.0000158712.42875.51. [DOI] [PubMed] [Google Scholar]
  • 49.Kotsimbos TC, Snell GI, Levvey B, Spelman DW, Fuller AJ, Wesselingh SL, et al. Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2005;79(3):269–275. doi: 10.1097/01.tp.0000149839.87843.64. [DOI] [PubMed] [Google Scholar]
  • 50.Pokorny H, Langer F, Herkner H, Schernberger R, Plochl W, Soliman T, et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant. 2005;19(4):532–536. doi: 10.1111/j.1399-0012.2005.00384.x. [DOI] [PubMed] [Google Scholar]
  • 51.Hsu RB, Chen RJ, Wang SS, Chu SH. Incidence of serum creatine kinase elevation and its relation to medications used after heart transplantation. Clin Transplant. 2005;19(1):45–50. doi: 10.1111/j.1399-0012.2004.00293.x. [DOI] [PubMed] [Google Scholar]
  • 52.Del Gaudio M, Grazi GL, Ercolani G, Ravaioli M, Varotti G, Cescon M, et al. Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. Clin Transplant. 2005;19(3):399–405. doi: 10.1111/j.1399-0012.2005.00363.x. [DOI] [PubMed] [Google Scholar]
  • 53.Takatsuka H, Nakajima T, Nomura K, Wakae T, Toda A, Itoi H, et al. Heparin-induced thrombocytopenia antibody and the pathogenesis of thrombotic microangiopathy after stem cell transplantation. Clin Transplant. 2005;19(3):418–422. doi: 10.1111/j.1399-0012.2005.00367.x. [DOI] [PubMed] [Google Scholar]
  • 54.Molnar MZ, Novak M, Ambrus C, Kovacs A, Pap J, Remport A, et al. Anemia in kidney transplanted patients. Clin Transplant. 2005;19(6):825–833. doi: 10.1111/j.1399-0012.2005.00428.x. [DOI] [PubMed] [Google Scholar]
  • 55.Lee S, Coco M, Greenstein SM, Schechner RS, Tellis VA, Glicklich DG. The effect of sirolimus on sex hormone levels of male renal transplant recipients. Clin Transplant. 2005;19(2):162–167. doi: 10.1111/j.1399-0012.2005.00257.x. [DOI] [PubMed] [Google Scholar]
  • 56.Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant. 2005;19(4):433–455. doi: 10.1111/j.1399-0012.2005.00378.x. [DOI] [PubMed] [Google Scholar]
  • 57.Gruber SA, Garnick J, Morawski K, Sillix DH, West MS, Granger DK, et al. Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus. Clin Transplant. 2005;19(2):273–278. doi: 10.1111/j.1399-0012.2005.00337.x. [DOI] [PubMed] [Google Scholar]
  • 58.Baggio B, Budakovic A, Perissinotto E, Maggi S, Cantaro S, Enzi G, et al. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA) Nephrol Dial Transplant. 2005;20(1):114–123. doi: 10.1093/ndt/gfh553. [DOI] [PubMed] [Google Scholar]
  • 59.Nishimura M, Hashimoto T, Kobayashi H, Fukuda T, Okino K, Yamamoto N, et al. Close association of Chlamydia pneumoniae IgA seropositivity by ELISA with the presence of coronary artery stenosis in haemodialysis patients. Nephrol Dial Transplant. 2005;20(9):1944–1950. doi: 10.1093/ndt/gfh906. [DOI] [PubMed] [Google Scholar]
  • 60.Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant. 2005;20(1):167–175. doi: 10.1093/ndt/gfh541. [DOI] [PubMed] [Google Scholar]
  • 61.Stompor T, Krasniak A, Sulowicz W, Dembinska-Kiec A, Janda K, Wojcik K, et al. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant. 2005;20(2):404–412. doi: 10.1093/ndt/gfh597. [DOI] [PubMed] [Google Scholar]
  • 62.Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant. 2005;20(1):129–134. doi: 10.1093/ndt/gfh568. [DOI] [PubMed] [Google Scholar]
  • 63.Lim CT, Wong KS, Foo MW. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital. Nephrol Dial Transplant. 2005;20(8):1702–1706. doi: 10.1093/ndt/gfh860. [DOI] [PubMed] [Google Scholar]
  • 64.Kihara T, Miyata Y, Furukawa M, Noguchi M, Nishikido M, Koga S, et al. Predictive value of serum macrophage colony-stimulating factor for development of aortic calcification in haemodialysis patients: a 6 year longitudinal study. Nephrol Dial Transplant. 2005;20(8):1647–1652. doi: 10.1093/ndt/gfh879. [DOI] [PubMed] [Google Scholar]
  • 65.Kalantar-Zadeh K, McAllister CJ, Miller LG. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study. Nephrol Dial Transplant. 2005;20(8):1662–1669. doi: 10.1093/ndt/gfh895. [DOI] [PubMed] [Google Scholar]
  • 66.Rostand SG, Cliver SP, Goldenberg RL. Racial disparities in the association of foetal growth retardation to childhood blood pressure. Nephrol Dial Transplant. 2005;20(8):1592–1597. doi: 10.1093/ndt/gfh833. [DOI] [PubMed] [Google Scholar]
  • 67.Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant. 2005;20(8):1598–1603. doi: 10.1093/ndt/gfh809. [DOI] [PubMed] [Google Scholar]
  • 68.Bailie GR, Eisele G, Liu L, Roys E, Kiser M, Finkelstein F, et al. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant. 2005;20(6):1110–1115. doi: 10.1093/ndt/gfh771. [DOI] [PubMed] [Google Scholar]
  • 69.Duman D, Tokay S, Toprak A, Oktay A, Ozener IC, Unay O. Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant. 2005;20(5):962–967. doi: 10.1093/ndt/gfh741. [DOI] [PubMed] [Google Scholar]
  • 70.DeLong M, Logan JL, Yong KC, Lien YH. Renin-angiotensin blockade reduces serum free testosterone in middle-aged men on haemodialysis and correlates with erythropoietin resistance. Nephrol Dial Transplant. 2005;20(3):585–590. doi: 10.1093/ndt/gfh638. [DOI] [PubMed] [Google Scholar]
  • 71.Ortega T, Ortega F, Diaz-Corte C, Rebollo P, Ma Baltar J, Alvarez-Grande J. The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management. Nephrol Dial Transplant. 2005;20(3):598–603. doi: 10.1093/ndt/gfh644. [DOI] [PubMed] [Google Scholar]
  • 72.Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, et al. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2005;20(4):735–742. doi: 10.1093/ndt/gfh766. [DOI] [PubMed] [Google Scholar]
  • 73.Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, et al. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant. 2005;20(4):760–767. doi: 10.1093/ndt/gfh611. [DOI] [PubMed] [Google Scholar]
  • 74.Taniwaki H, Ishimura E, Tabata T, Tsujimoto Y, Shioi A, Shoji T, et al. Aortic calcification in haemodialysis patients with diabetes mellitus. Nephrol Dial Transplant. 2005;20(11):2472–2478. doi: 10.1093/ndt/gfi039. [DOI] [PubMed] [Google Scholar]
  • 75.van Ree RM, de Vries AP, Oterdoom LH, The TH, Gansevoort RT, Homan van der Heide JJ, et al. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. Nephrol Dial Transplant. 2005;20(11):2524–2531. doi: 10.1093/ndt/gfi052. [DOI] [PubMed] [Google Scholar]
  • 76.Rosenberger J, van Dijk JP, Nagyova I, Roland R, Geckova AM, van den Heuvel WJ, et al. Do dialysis- and transplantation-related medical factors affect perceived health status? Nephrol Dial Transplant. 2005;20(10):2153–2158. doi: 10.1093/ndt/gfh965. [DOI] [PubMed] [Google Scholar]
  • 77.Kutner NG, Zhang R, Barnhart H, Collins AJ. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant. 2005;20(10):2159–2167. doi: 10.1093/ndt/gfh973. [DOI] [PubMed] [Google Scholar]
  • 78.Sharma R, Pellerin D, Gaze DC, Gregson H, Streather CP, Collinson PO, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant. 2005;20(10):2207–2214. doi: 10.1093/ndt/gfi005. [DOI] [PubMed] [Google Scholar]
  • 79.Blazik M, Hutchinson P, Jose MD, Polkinghorne KR, Holdsworth SR, Atkins RC, et al. Leukocyte phenotype and function predicts infection risk in renal transplant recipients. Nephrol Dial Transplant. 2005;20(10):2226–2230. doi: 10.1093/ndt/gfi007. [DOI] [PubMed] [Google Scholar]
  • 80.Losito A, Errico R, Santirosi P, Lupattelli T, Scalera GB, Lupattelli L. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant. 2005;20(8):1604–1609. doi: 10.1093/ndt/gfh865. [DOI] [PubMed] [Google Scholar]
  • 81.Manhes G, Heng AE, Aublet-Cuvelier B, Gazuy N, Deteix P, Souweine B. Clinical features and outcome of chronic dialysis patients admitted to an intensive care unit. Nephrol Dial Transplant. 2005;20(6):1127–1133. doi: 10.1093/ndt/gfh762. [DOI] [PubMed] [Google Scholar]
  • 82.Myllymaki J, Honkanen T, Syrjanen J, Helin H, Rantala I, Pasternack A, et al. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant. 2005;20(1):89–95. doi: 10.1093/ndt/gfh584. [DOI] [PubMed] [Google Scholar]
  • 83.Wang Y, Ng MC, So WY, Ma R, Ko GT, Tong PC, et al. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients. Nephrol Dial Transplant. 2005;20(12):2733–2738. doi: 10.1093/ndt/gfi101. [DOI] [PubMed] [Google Scholar]
  • 84.Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, et al. The spectrum of infection-related morbidity in hospitalized haemodialysis patients. Nephrol Dial Transplant. 2005;20(6):1180–1186. doi: 10.1093/ndt/gfh729. [DOI] [PubMed] [Google Scholar]
  • 85.Branten AJ, Vervoort G, Wetzels JF. Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant. 2005;20(4):707–711. doi: 10.1093/ndt/gfh719. [DOI] [PubMed] [Google Scholar]
  • 86.Bert F, Bellier C, Lassel L, Lefranc V, Durand F, Belghiti J, et al. Risk factors for Staphylococcus aureus infection in liver transplant recipients. Liver Transpl. 2005;11(9):1093–1099. doi: 10.1002/lt.20491. [DOI] [PubMed] [Google Scholar]
  • 87.Slifkin M, Ruthazer R, Freeman R, Bloom J, Fitzmaurice S, Fairchild R, et al. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation. Liver Transpl. 2005;11(12):1597–1602. doi: 10.1002/lt.20523. [DOI] [PubMed] [Google Scholar]
  • 88.Wigg AJ, Gunson BK, Mutimer DJ. Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients. Liver Transpl. 2005;11(1):27–34. doi: 10.1002/lt.20289. [DOI] [PubMed] [Google Scholar]
  • 89.Guy JE, Qian P, Lowell JA, Peters MG. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl. 2005;11(10):1252–1257. doi: 10.1002/lt.20511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Fouquet V, Alves A, Branchereau S, Grabar S, Debray D, Jacquemin E, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl. 2005;11(2):152–160. doi: 10.1002/lt.20358. [DOI] [PubMed] [Google Scholar]
  • 91.Benlloch S, Berenguer M, Prieto M, Rayon JM, Aguilera V, Berenguer J. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index. Liver Transpl. 2005;11(4):456–462. doi: 10.1002/lt.20381. [DOI] [PubMed] [Google Scholar]
  • 92.Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection? Liver Transpl. 2005;11(6):700–704. doi: 10.1002/lt.20417. [DOI] [PubMed] [Google Scholar]
  • 93.Herrero JI, Lorenzo M, Quiroga J, Sangro B, Pardo F, Rotellar F, et al. De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl. 2005;11(1):89–97. doi: 10.1002/lt.20319. [DOI] [PubMed] [Google Scholar]
  • 94.Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl. 2005;11(10):1265–1272. doi: 10.1002/lt.20549. [DOI] [PubMed] [Google Scholar]
  • 95.Santoro-Lopes G, de Gouvea EF, Monteiro RC, Branco RC, Rocco JR, Halpern M, et al. Colonization with methicillin-resistant Staphylococcus aureus after liver transplantation. Liver Transpl. 2005;11(2):203–209. doi: 10.1002/lt.20338. [DOI] [PubMed] [Google Scholar]
  • 96.Sieders E, Hepkema BG, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, et al. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA- DR antigens on the outcome after pediatric liver transplantation. Liver Transpl. 2005;11(12):1541–1549. doi: 10.1002/lt.20521. [DOI] [PubMed] [Google Scholar]
  • 97.Corradini SG, Elisei W, De Marco R, Siciliano M, Iappelli M, Pugliese F, et al. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl. 2005;11(2):140–151. doi: 10.1002/lt.20339. [DOI] [PubMed] [Google Scholar]
  • 98.Samonakis DN, Triantos CK, Thalheimer U, Quaglia A, Leandro G, Teixeira R, et al. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transpl. 2005;11(4):386–395. doi: 10.1002/lt.20344. [DOI] [PubMed] [Google Scholar]
  • 99.Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl. 2005;11(9):1073–1079. doi: 10.1002/lt.20427. [DOI] [PubMed] [Google Scholar]
  • 100.Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Orthotopic liver transplantation for biliary atresia: the U.S. experience. Liver Transpl. 2005;11(10):1193–1200. doi: 10.1002/lt.20509. [DOI] [PubMed] [Google Scholar]
  • 101.Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl. 2005;11(11):1361–1369. doi: 10.1002/lt.20444. [DOI] [PubMed] [Google Scholar]
  • 102.Kawut SM, Taichman DB, Ahya VN, Kaplan S, Archer-Chicko CL, Kimmel SE, et al. Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl. 2005;11(9):1107–1111. doi: 10.1002/lt.20459. [DOI] [PubMed] [Google Scholar]
  • 103.Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl. 2005;11(12):1481–1493. doi: 10.1002/lt.20519. [DOI] [PubMed] [Google Scholar]
  • 104.Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl. 2005;11(3):281–289. doi: 10.1002/lt.20357. [DOI] [PubMed] [Google Scholar]
  • 105.Levitsky J, Kalil A, Meza JL, Hurst GE, Freifeld A. Herpes zoster infection after liver transplantation: a case-control study. Liver Transpl. 2005;11(3):320–325. doi: 10.1002/lt.20356. [DOI] [PubMed] [Google Scholar]
  • 106.Grady KL, Naftel D, Pamboukian SV, Frazier OH, Hauptman P, Herre J, et al. Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change. J Heart Lung Transplant. 2005;24(9):1424–1430. doi: 10.1016/j.healun.2004.08.010. [DOI] [PubMed] [Google Scholar]
  • 107.Weaver JG, McGregor CG, Tazelaar HD, Badley AD. Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation. J Heart Lung Transplant. 2005;24(7):841–847. doi: 10.1016/j.healun.2004.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Ragette R, Kamler M, Weinreich G, Teschler H, Jakob H. Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring. J Heart Lung Transplant. 2005;24(9):1315–1319. doi: 10.1016/j.healun.2004.09.001. [DOI] [PubMed] [Google Scholar]
  • 109.Grady KL, Naftel DC, White-Williams C, Bellg AJ, Young JB, Pelegrin D, et al. Predictors of quality of life at 5 to 6 years after heart transplantation. J Heart Lung Transplant. 2005;24(9):1431–1439. doi: 10.1016/j.healun.2004.08.012. [DOI] [PubMed] [Google Scholar]
  • 110.Whelan TP, Dunitz JM, Kelly RF, Edwards LB, Herrington CS, Hertz MI, et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant. 2005;24(9):1269–1274. doi: 10.1016/j.healun.2004.10.014. [DOI] [PubMed] [Google Scholar]
  • 111.Fusar-Poli P, Martinelli V, Klersy C, Campana C, Callegari A, Barale F, et al. Depression and quality of life in patients living 10 to 18 years beyond heart transplantation. J Heart Lung Transplant. 2005;24(12):2269–2278. doi: 10.1016/j.healun.2005.06.022. [DOI] [PubMed] [Google Scholar]
  • 112.Pauliks LB, Pietra BA, Kirby S, Logan L, DeGroff CG, Boucek MM, et al. Altered ventricular mechanics in cardiac allografts: a tissue Doppler study in 30 children without prior rejection events. J Heart Lung Transplant. 2005;24(11):1804–1813. doi: 10.1016/j.healun.2004.05.032. [DOI] [PubMed] [Google Scholar]
  • 113.Pilcher DV, Snell GI, Scheinkestel CD, Bailey MJ, Williams TJ. High donor age, low donor oxygenation, and high recipient inotrope requirements predict early graft dysfunction in lung transplant recipients. J Heart Lung Transplant. 2005;24(11):1814–1820. doi: 10.1016/j.healun.2005.04.003. [DOI] [PubMed] [Google Scholar]
  • 114.Ruttmann E, Ulmer H, Marchese M, Dunst K, Geltner C, Margreiter R, et al. Evaluation of factors damaging the bronchial wall in lung transplantation. J Heart Lung Transplant. 2005;24(3):275–281. doi: 10.1016/j.healun.2004.01.008. [DOI] [PubMed] [Google Scholar]
  • 115.Langenbach SY, Zheng L, McWilliams T, Levvey B, Orsida B, Bailey M, et al. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome. J Heart Lung Transplant. 2005;24(10):1550–1556. doi: 10.1016/j.healun.2004.11.008. [DOI] [PubMed] [Google Scholar]
  • 116.Radovancevic B, Golino A, Vrtovec B, Thomas CD, Radovancevic R, Odegaard P, et al. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease? J Heart Lung Transplant. 2005;24(6):703–707. doi: 10.1016/j.healun.2004.03.025. [DOI] [PubMed] [Google Scholar]
  • 117.Gardner RS, Henderson G, McDonagh TA. The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones? J Heart Lung Transplant. 2005;24(3):303–309. doi: 10.1016/j.healun.2004.01.010. [DOI] [PubMed] [Google Scholar]
  • 118.Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–1379. doi: 10.1016/s0895-4356(96)00236-3. [DOI] [PubMed] [Google Scholar]
  • 119.Bergstralh EJ, Kosanke JL, Jacobsen SJ. Software for optimal matching in observational studies. Epidemiology. 1996;7(3):331–332. [PubMed] [Google Scholar]
  • 120.Cepeda MS, Boston R, Farrar JT, Strom BL. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol. 2003;158(3):280–287. doi: 10.1093/aje/kwg115. [DOI] [PubMed] [Google Scholar]

RESOURCES